Markets:

Overview

News

Currencies

International

Treasuries

Tilray Brands, Inc. - Common Stock (NQ:TLRY)

7.750 -0.140 (-1.77%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Tilray Brands, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Canopy Growth or Tilray Brands: Which Stock Is More Likely to Be a Millionaire Maker? ↗

February 20, 2026

Don't bet on either one to pull that off.

Via The Motley Fool

Topics Cannabis Government

Tilray To Produce And Distribute Carlsberg Beer Brands In US – Stock Gains 4% ↗

February 18, 2026

The multi-year licensing agreement with the Danish brewing giant will allow Tilray to produce and distribute several Carlsberg beer brands in all U.S. channels starting Jan. 1, 2027.

Via Stocktwits

Tilray Lands Exclusive Carlsberg US Brewing Deal ↗

February 18, 2026

Tilray stock rose after it landed an exclusive multi-year U.S. licensing deal to produce and distribute several Carlsberg-branded beers.

Via Benzinga

Peering Into Tilray Brands Inc's Recent Short Interest ↗

February 17, 2026

Via Benzinga

Is Tilray Stock Going to $0? ↗

February 10, 2026

The company isn't in good financial shape, and there's still plenty of risk with the stock.

Via The Motley Fool

Topics Cannabis Law Enforcement

What's Going On With Tilray Stock Today? ↗

January 22, 2026

Tilray shares edged higher in premarket trading after the company rebranded its Italy unit as Tilray Medical Italia and highlighted expansion plans in the regulated medical cannabis market.

Via Benzinga

Topics Cannabis

Tilray Brands Just Posted Record Numbers for Q2. Is the Stock a Buy? ↗

January 21, 2026

The company's international cannabis sales soared by 36%, and it cut its losses in half.

Via The Motley Fool

Topics Cannabis Government

This Beaten-Down Stock Just Posted Record Revenue. Is It Finally Time to Buy? ↗

January 20, 2026

One strong quarter hardly makes up for the past few years.

Via The Motley Fool

Topics Cannabis Government

The High Stakes of Reform: Canopy Growth Navigates a Volatile Regulatory Labyrinth in 2026

January 09, 2026

As of January 9, 2026, the cannabis sector finds itself at a historic crossroads, caught between the euphoria of federal progress and the harsh reality of market mechanics. Following a landmark...

Via MarketMinute

Topics Bankruptcy Cannabis ETFs

Tilray Valuation Attractive With Strong Growth Overseas, Analyst Says ↗

January 09, 2026

Via Benzinga

TLRY Stock In Focus After Alliance Global Halves Price Target ↗

January 09, 2026

Alliance Global cut TLRY’s target price to $10 from $20, citing limited visibility into the company’s long-term sales trajectory and cash flow.

Via Stocktwits

Topics Cannabis

Tilray Stock Jumps After Revenue, Earnings Beat ↗

January 09, 2026

Tilray Brands, Inc. (NASDAQ:TLRY) shares are trading higher after the company reported better-than-expected second quarter financial results.

Via Benzinga

Stock Market Today: Nasdaq 100, S&P 500 Futures Gain As Investors Await December Jobs Report— General Motors, Offerpad, Tilray In Focus ↗

January 09, 2026

U.S. stock futures pared earlier losses to advance on Friday after a mixed Thursday. Futures of major benchmark indices were trading higher.

Via Benzinga

Why Tilray Brands Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket ↗

January 09, 2026

Via Benzinga

Nasdaq, S&P 500 Futures Pause Ahead Of Jobs Report, Trump Tariff Ruling: Why OPEN, INTC, NVDA, TLRY, CRMD, GLUE Are On Traders' Radar Today ↗

January 09, 2026

Via Stocktwits

Topics Government Stocks

Why Tilray Brands Stock Is Rising in After-Hours Trading ↗

January 08, 2026

Tilray had good things to say about its recent quarter -- and investors were listening.

Via The Motley Fool

Topics Cannabis

Tilray Stock Fires Up After Record Q2 Earnings: Here's Why ↗

January 08, 2026

Here's a detailed look inside the Q2 earnings report from Tilray Brands.

Via Benzinga

Tilray (TLRY) Earnings Tonight: Wall Street Expects A Loss, Bulls Are Betting On This ↗

January 08, 2026

Tilray shares are flat Thursday morning as the company prepares to report its fiscal second-quarter 2026 results after the bell, stirring investor interest.

Via Benzinga

A Look Ahead: Tilray Brands's Earnings Forecast ↗

January 07, 2026

Via Benzinga

Top Wall Street Forecasters Revamp Tilray Brands Expectations Ahead Of Q2 Earnings ↗

January 07, 2026

Via Benzinga

Tilray Q2: High Hopes or Harsh Reality? ↗

January 06, 2026

As Canadian cannabis king Tilray prepares to report its fiscal Q2 results on Thursday, the company stands at a crossroads.

Via Benzinga

Topics Cannabis

Tilray Stock Forms A Risky Pattern: Jan. 8 Will Be Key ↗

January 06, 2026

Tilray's stock price has been highly volatile in the past few months.

Via Talk Markets

Top Stocks With Earnings This Week: Tilray, Applied Digital and More ↗

January 05, 2026

This week's earnings calendar features a mix of early reports in the cannabis, AI infrastructure and consumer goods sectors.

Via Benzinga

Topics Artificial Intelligence Cannabis

How Long Will the Cannabis Stock Rally Last? ↗

January 01, 2026

Don't press the buy button just yet.

Via The Motley Fool

Topics Cannabis Economy Government

The 2026 Cannabis Wildcard: How Tax Reform Could Reset Stock Valuations ↗

December 30, 2025

Via MarketBeat

Topics Cannabis

I Was Right: President Trump Will Legalize Marijuana in 2026 ↗

December 28, 2025

The marijuana business just got a little easier in America -- and maybe a whole lot more profitable.

Via The Motley Fool

Topics Cannabis Government

This Stock Has Almost Tripled in 6 Months. Here's What Investors Need to Watch Next ↗

December 24, 2025

Is it too late to jump on the bandwagon?

Via The Motley Fool

Topics Cannabis Government

Everything Investors Need to Know About President Trump's Executive Order Reclassifying Marijuana as a Lower Class of Drug ↗

December 23, 2025

President Donald Trump just signed an executive order that reclassified marijuana from a Schedule I narcotic to Schedule III.

Via The Motley Fool

Topics Cannabis Government

President Trump Just Reclassified Marijuana. Are Green Thumb, Tilray, and Trulieve Stocks No-Brainer Buys? ↗

December 23, 2025

These cannabis companies could soon see more green thanks to the president's milestone decision.

Via The Motley Fool

Topics Cannabis Government Law Enforcement

The Green Resurgence: Tilray and Cannabis Sector Skyrocket Following Landmark Executive Action

December 19, 2025

The cannabis sector is experiencing a historic "Santa Claus rally" this December, with stock prices surging across the board following a transformative shift in federal policy. Today, December 19,...

Via MarketMinute

Topics Cannabis

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.